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Isolated hereditary deficiency of C2 in man has been shown to be transmitted
as an autosomal recessive trait (1-5) . Recently, Fu et al . demonstrated that
hereditary C2 deficiency segregated within a single family in close linkage to a
particular HL-A haplotype, HL-A10,W18 (6) . Genetic studies by Allen (7) have
shown that the genetic polymorphism of factor B (C3 proactivator, glycine-rich
ß-glycoprotein), a component of the alternate pathway, is controlled by a gene
located within the major histocompatibility region (MHR) .
The genetic control of hemolytic complement (C) in mice is also governed by
genes within the H-2 system (8) . These genes map very closely to the Ss-Slp
region and there is evidence that the protein, Ss, is in fact a component of the C
system in these animals (9,10) . Ferreira and Nussenzweig recently showed that
serum C3 levels in mice are determined by gene(s) linked with the H-2 complex
(11) . These findings indicate that the MHR in mice as well as in man is involved
in the genetic control of the C system . In the present study, we have investigated
another larger pedigree of paternal members of a C2-deficient patient. This
patienthas been previously described to have systemic lupus erythematosus (12) .
Materials and Methods
Buffers used for C assays ; EDTA, gelatin veronal buffer, and glucose gelatin veronal buffer (ggvb)
with and without metals (Mg++ and Ca-) have been described by Mayer (13) . Intermediate cells
EAC1 6P,4"° were prepared according to the method of Borsos and Rapp (14) . Tma , < 5 min .
Method of Titration of C2 . Sera for C2 titration were diluted in ggvb++ in 0 .5-ml vol . 0.5 ml
EAC19P,4"° cells (Tmax < 5 min) at aconcentration of 1 x 108/ml were added to each tube. The tubes
were incubated at 30°C for Tma, time . 0.5 ml of 0.01MEDTA was added to each tube, followed by 1
ml of guinea pig C 1/25 dilution in 0.04MEDTA solution . The tubes were incubated at 37°C for 90
min, diluted with 5 ml of normal saline to stop the reaction, centrifuged, supernatant fluids read at
412 jam, and CH50 obtained as described previously (13) .
HL-A Typing .
￿
Astandard one-step lymphocytotoxicity test describedby Kissmeyer-Nielsen (15)
wasused . Mono- and duospecific typing sera determining allW. H. O. definedHL-A specificities and
most Workshop specificities were applied . The results of HL-A typing and the haplotyping of the
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THE JOURNAL OF EXPERIMENTAL MEDICINE - VOLUME 141, 1975family were carried out independently and without prior knowledge of the actual C2 levels in the
serum of these individuals .
Results
94 family members of the paternal side of the C2-deficient patient were
accounted for (Fig . 1) . The individuals are numbered consecutively in the figure .
The hemolytic C2 levels of 64 members and the HL-A typing of 58 members are







The pedigree of thepaternal members of the C2-deficient SLE patient . The shaded
areas represent the hemolytic C2 values . These levels were 2 SD below the normal mean .
(Normal mean of 40 healthy adults, 1,350 CH50 U/ml 1500.) TheHL-A typing is represented
below each individual .
represented in Tables 1, 11, 111, and IV . The legend for the HL-A typing is
presented in Fig. 2. In Table I, with the exception of one individual (no. 36), all
the others (27 individuals) had low hemolytic C2 levels associated with an
infrequent HL-A haplotype 2,4A2* . This was generally consistent, irrespective of
whether the determinations were carried out once or on three different samples .
Individual no . 36 with HL-A2,4A2* haplotype had elevated C2 levels at two
different occasions (average, 2,488 CH50 U/ml). Another unusual finding was




Low Hemolytic C2 Levels of Individuals Carrying HL-A2,4A2* Haplotype
$ See Fig . 1 .
§N, normal, 1,350 t500CH50 U/ml ; (1), below 1 SD and (1), above 1 SD : 850-1,850CH50 U/ml ; (11), below 2 SD :
(11), above 2SD, 350-2,350 CH50 U/ml . These symbolsand this legend are thesame for Tables II, III, and IV .
11 See Fig . 2 .




Low Hemolytic C2 Levels of Individuals
￿




* See Fig . 1 .
￿
*See Fig . 1 .
$See footnote (§) of Table I .
￿
$See footnote (§) of Table 1 .
§ See Fig . 2 . § See Fig . 2 .
11 Mean of determinations on three separate samples .
￿
11 HL-AW25,W18 is the same as HL-Al0,W18 .
HL-All
carried the haplotype 2,W18 which was also associated with low levels of C2
(Table II) . This haplotype was transmitted totwo of her three children (nos . 78 and
80). C2 levels were low in all three individuals (250, 503, and 150 CH50 U/ml,
respectively) .
Most important of all were the findings that in the parents and siblings of the
homozygous C2-deficient patient, a third haplotype associated with low C2
values was introduced, HL-A10,W18 (Table III) . This haplotype, 10,W18 was
found in the mother (no. 26) of the homozygous C2-deficient patient (no . 61) and
one of the two children (no . 62) both of which were heterozygous for C2 .
Furthermore, the homozygous C2-deficient patient (no . 61) carried this hap-
lotype . The C2 levels of the remaining individuals and their HL-A typing-in the
family are presented in Table IV . Either normal or elevated levels were present .
Discussion
Family studies of the paternal members of a patient associated with C2
deficiency and systemic lupus erythematosus (SLE) indicated that the C2
deficiency was inherited as an autosomal recessive trait . Hemolytic C2 levels in
No . ofindividual$ C2 levels§ HL-All No . of individual$ C2 levels§
4Q 63511 A/D 53 15811 A/D
EM 62611 A/D 54 26511 A
16 62611 A/D 55 47011 A
18 18411 A/D 56 49011 A
22 83011 A/G 61 <511 A/f
23M 78111 A/X 64 73011 A/R
25 36011 A/O 65 65511 A/a
27 61711 A/Z 671 22811 A/c
29T 45011 A/o 84~ 43011 A/F
36T 2,4881] AYH 86 13011 A/F
40 16411 A/H 87 25011 A/F
48T 58711 A/E 88$ 42811 A/G
51 79011 A/D 89q 45211 A/F
52 21511 AB 911 40411 A/G
No. ofindividual* C2 levels$ HL-A§ No . of individual* C2 levels$ HL-A§
4511 25011 UN 26 27011 f/R11
7811 50311 U/Q 61 <511 A/fll
8011 15011 U/T 62 34011 o/fllTABLE IV
Normal or Elevated Hemolytic C2 Levels of Individuals and TheirHL-A Typing





*See Fig . 1 .
*See footnote (§) of Table I.
§See Fig . 2.
11 Mean of determinations on three separate samples .
4 ND, not done .
the heterozygous-carrier state were in general 50% or less of normal values . HL-A
typing of this family indicated that the homozygous C2-deficient patient
inherited HL-A10,W18 from his mother and HL-A2,4A2* from his father . Two
out of four siblings from this family were heterozygote for C2 and these siblings
carried one of these haplotypes .
94 family members were accounted for and it was demonstrated that 28
members carried the 2,4A2* haplotype and of these 27 members were also
heterozygote with respect to C2 levels . Onemember carrying this haplotype (no .
36), 2,4A2* had elevated C2 levels suggesting a recombination between the C2
gene and the HL-A . The HL-A2,4A2* is an infrequent haplotype, the gene
frequency being 0.173% in a normal unrelated Danish population .
-10,W5
f - W25,W18
FiG . 2 .
￿
Fig . 2 represents the haplotypes in Fig. 1 . "/" representing HL-AW25, W18 is the
same as HL-A10,W18 .
No . of individual* C2 levels$ HL-A§ No . ofindividual* C2 levels$ HL-A§
12 1,827N N/Q 4911 1,765 N F/G
19 1,350 N B/C I 57 1,386 N X/d
21 2,500TT ND 59 1,134 N X/Y
2411 2,2911 d/Y 63 1,490 N O/R
3011 2,68611 b/c 66 1,386 N Z/a
3211 1,8601 H/D 6811 1,178 N O/c
3311 1,580 N ND 69 1,764N M/H
34 1,235 N H/D 70 1,386 N ND4
3511 2,68611 K/L 7111 2,3251 ND
3711 2,975TT I/J 7211 3,160T T ND
38 2,71011 D/H j 7411 2,790TT ND
3911 1,8961 D/Ii 75 1,084 N S/W
42 2,2601 ND 7911 1,401 N V/Q
43 1,575N N/S 81 1,750 N P/O
4411 2,133T T/Q 8511 2,760TT E/F








H - W19,W5,315 W- 2,W10
1 -2,W16 X-29,12
J - 2,W5 Y-1,17
K-2,12 Z-11,W10,315
L - 29,17 a-2,8
M- -,W2 b- 2,5,315
N- 2,27 c-3,5
O- 2.13 d- 9,71468
￿
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Thecommon occurrence of this low frequency haplotype 2,4A2* in our pedigree
strongly indicates that this particular haplotype is inherited in this family . The
haplotype 10,W18, which is expressed more frequently in the general population,
was evident in the mother and two siblings ofour homozygous C2-deficient SLE
patient . It is of particular interest that this haplotype 10,W18 was expressed in
association with C2 deficiency and lupus-like syndrome by Fu et al . (6) . Studies
of HL-A antigens in two families with hereditary Clr deficiency indicate that a
gene controlling serum levels of this component does not segregate in linkage
with the HL-A region although in one family, the homozygous Clr-deficient va-
tient was homozygous for HL-A2, W10 haplotype.l In the other family, the
homozygous Clr-deficient individuals (brother and sister) are currently under
investigation for HL-A typing by us .'
The influence of determinants within the MHR on disease susceptibility
and/or resistance has been the subject of intense investigation in both the
experimental animals and in man. The inclusion of a third modality (i.e ., the C
system) in the immunological host defense, to the HL-A region, within which
genetic control of immune responses are located are of significance for under-
standing the relationship between certain diseases, HL-A antigens, and C
deficiencies . Differences in disease susceptibility could be explained by the
possible occurrence of genetic polymorphism within severalof theC components .
Summary
Hereditary C2-deficiency has been shown to be transmitted as an autosomal
recessive characteristic . Recent evidence indicates that some genetic factors
involved in the control of the complement (C) system in both man and mice are
governed by genes localized within the major histocompatibility region . This
study describes a large pedigree of the paternal family of a C2-deficient patient
with systemic lupus erythematosus . It is shown that this condition is transmitted
as an autosomal recessive trait, the heterozygous carriers having approximately
half normal levels of C2 . Furthermore, this trait was shown to be inherited in
close linkage with an infrequent HL-A type, 2,4A2* . The maternal, C2-defective
chromosome was shown to be transmitted by HL-AW10,W18 haplotype . This
same haplotype was described in a similar study by Fu et al . (6) to be associated
with C2 deficiency . Finally, a third haplotype HL-A2,W18 carrying a defective
C2 gene was demonstrated in a part of this pedigree .
The authors are grateful to the technical staff of the Complement and Tissue Typing Laboratories of
Sloan-Kettering Institute, New York, for their invaluable assistance in performing the tests .
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